Literature DB >> 11231921

Accumulation of triglyceride-rich lipoprotein in subjects with abdominal obesity: the biguanides and the prevention of the risk of obesity (BIGPRO) 1 study.

J M Bard1, M A Charles, I Juhan-Vague, P Vague, P André, M Safar, J C Fruchart, E Eschwege.   

Abstract

The present study represents a new insight into the Biguanides and the Prevention of the Risk of Obesity (BIGPRO) 1 study population at inclusion. This population, selected basically on the basis of a high waist-to-hip ratio (>/=0.95 for men and >/=0.80 for women), is supposed to represent a group of patients with insulin resistance. The present study was undergone to establish whether apolipoprotein C-III (apoC-III) and apolipoprotein E (apoE) associated with apo B (apoC-III LpB and apoE LpB, respectively), considered to be markers of remnant accumulation, play a role in the hypertriglyceridemia associated with insulin resistance and whether they are related to other biological abnormalities frequently observed in this syndrome. In this population, the concentration of the markers of remnant accumulation increases with triglyceride levels. Therefore, correlation studies were realized to assess the relative effect of insulin and the markers of remnant accumulation on triglyceride plasma level. As a first attempt, a simple correlation analysis revealed that insulin is positively related to the markers of remnant accumulation only in hypertriglyceridemic patients (triglycerides >/=1.7 mmol/L). To assess the independent contribution of these markers, insulin, and other parameters related to the plasma triglyceride concentration, a stepwise multiple regression analysis was run. Results revealed that insulin and the markers of remnant accumulation (specifically, apoE LpB) are independent contributors to the plasma triglyceride concentration. Markers of the endothelial damage, plasminogen activator inhibitor-1, tissue plasminogen activator, and von Willebrand factor, which are often increased in the case of insulin resistance, were tested for their correlation with the markers of remnant accumulation. Plasminogen activator inhibitor-1 is positively correlated with these markers only in hypertriglyceridemic male subjects. It is concluded that increased insulin levels found in insulin resistance syndrome are associated with an increased production of triglyceride-rich lipoproteins enriched in apoC-III and apoE. The accumulation of these remnants and/or their abnormal composition in apoC-III and apoE could be an explanation for the development of hypertriglyceridemia in this syndrome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11231921     DOI: 10.1161/01.atv.21.3.407

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  13 in total

1.  Ethnicity and nonalcoholic fatty liver disease in an obesity clinic: the impact of triglycerides.

Authors:  Eric R Kallwitz; Mrudula Kumar; Radhika Aggarwal; Reed Berger; Jennifer Layden-Almer; Neil Gupta; Scott J Cotler
Journal:  Dig Dis Sci       Date:  2008-03-18       Impact factor: 3.199

Review 2.  Role of triglyceride-rich lipoproteins in diabetic nephropathy.

Authors:  John C Rutledge; Kit F Ng; Hnin H Aung; Dennis W Wilson
Journal:  Nat Rev Nephrol       Date:  2010-05-04       Impact factor: 28.314

3.  Transplantation or removal of intra-abdominal adipose tissue prevents age-induced glucose insensitivity.

Authors:  Michelle T Foster; Haifei Shi; Randy J Seeley; Stephen C Woods
Journal:  Physiol Behav       Date:  2010-06-04

4.  ATF4 protein deficiency protects against high fructose-induced hypertriglyceridemia in mice.

Authors:  Guozhi Xiao; Ting Zhang; Shibing Yu; Sojin Lee; Virtu Calabuig-Navarro; Jun Yamauchi; Steven Ringquist; H Henry Dong
Journal:  J Biol Chem       Date:  2013-07-25       Impact factor: 5.157

5.  IRF-1 and miRNA126 modulate VCAM-1 expression in response to a high-fat meal.

Authors:  Chongxiu Sun; Kenan Alkhoury; Ying I Wang; Greg A Foster; Christopher E Radecke; Kayan Tam; Christina M Edwards; Marc T Facciotti; Ehrin J Armstrong; Anne A Knowlton; John W Newman; Anthony G Passerini; Scott I Simon
Journal:  Circ Res       Date:  2012-08-08       Impact factor: 17.367

6.  PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1.

Authors:  Shen Qu; Dongming Su; Jennifer Altomonte; Adama Kamagate; Jing He; German Perdomo; Tonia Tse; Yu Jiang; H Henry Dong
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-09-19       Impact factor: 4.310

7.  FoxO6 integrates insulin signaling with MTP for regulating VLDL production in the liver.

Authors:  Dae Hyun Kim; Ting Zhang; Sojin Lee; Virtu Calabuig-Navarro; Jun Yamauchi; Ann Piccirillo; Yong Fan; Radha Uppala; Eric Goetzman; H Henry Dong
Journal:  Endocrinology       Date:  2014-01-17       Impact factor: 4.736

Review 8.  Lipotoxicity as a trigger factor of renal disease.

Authors:  Adriana Izquierdo-Lahuerta; Cristina Martínez-García; Gema Medina-Gómez
Journal:  J Nephrol       Date:  2016-03-08       Impact factor: 3.902

9.  Association Between the Hypertriglyceridemic Waist Phenotype, Prediabetes, and Diabetes Mellitus Among Adults in Puerto Rico.

Authors:  Mary Vanellys Díaz-Santana; Erick L Suárez Pérez; Ana P Ortiz Martínez; Manuel Guzmán Serrano; Cynthia M Pérez Cardona
Journal:  J Immigr Minor Health       Date:  2016-02

Review 10.  FoxO1 integrates insulin signaling to VLDL production.

Authors:  Adama Kamagate; H Henry Dong
Journal:  Cell Cycle       Date:  2008-10-27       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.